Serina Therapeutics, Inc.·4

May 26, 4:26 PM ET

WILSON KAREN J 4

4 · Serina Therapeutics, Inc. · Filed May 26, 2026

Research Summary

AI-generated summary of this filing

Updated

Serina Therapeutics (SER) Director Karen J. Wilson Buys 20,000 Shares

What Happened
Karen J. Wilson, a director of Serina Therapeutics, reported two open-market purchases (code P). On 2026-05-21 she acquired 10,000 shares at a weighted-average price of $1.77 for $17,700, and on 2026-05-22 she acquired 10,000 shares at a weighted-average price of $1.93 for $19,300 — a total of 20,000 shares for $37,000. These were purchases (buying stock), which investors often view as a more informative signal than routine sales.

Key Details

  • Transaction dates and prices:
    • 2026-05-21: 10,000 shares, weighted-average $1.77 (total $17,700). Footnote F1: this reflects multiple trades between $1.76 and $1.79.
    • 2026-05-22: 10,000 shares, weighted-average $1.93 (total $19,300). Footnote F2: this reflects multiple trades between $1.90 and $1.95.
  • Total purchased: 20,000 shares for $37,000. Transaction code: P (purchase).
  • Shares owned after the transactions: not disclosed in the information provided in this summary/filing.
  • Filing timeliness: Form 4 filed 2026-05-26 for trades on 5/21 and 5/22; filing appears timely (filed within the SEC’s two-business-day window given the May 25 holiday).
  • Footnote notes: weighted-average prices reflect multiple executions; the reporting person will provide per-price breakdowns upon written SEC request.

Context
These were straightforward open-market purchases by a company director (not an option exercise, gift, or tax-related withholding). Purchases by insiders are frequently watched by retail investors as a potential signal of confidence, but they are not proof of future performance. No additional info (e.g., ownership totals or 10% status) was disclosed in the supplied filing details.

Insider Transaction Report

Form 4
Period: 2026-05-21
Transactions
  • Purchase

    Common Stock

    [F1]
    2026-05-21$1.77/sh+10,000$17,70010,000 total
  • Purchase

    Common Stock

    [F2]
    2026-05-22$1.93/sh+10,000$19,30020,000 total
Footnotes (2)
  • [F1]The price reflects the weighted average purchase price of multiple transactions ranging from a low purchase price of $1.76 per share to a high purchase price of $1.79 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each price.
  • [F2]The price reflects the weighted average purchase price of multiple transactions ranging from a low purchase price of $1.90 per share to a high purchase price of $1.95 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each price.
Signature
/s/ Karen J. Wilson|2026-05-26

Documents

1 file
  • 4
    wk-form4_1779827204.xmlPrimary

    FORM 4